Senior Associate of Strategy & Operations, Synapticure
More information about location
Providing personalized medicine for neurodegenerative patients
Be an early applicant
Providing personalized medicine for neurodegenerative patients
21-100 employees
Be an early applicant
More information about location
21-100 employees
Company mission
To provide neurodegenerative patients, starting with ALS and PD, access to the best care while fueling the advancement of personalized treatments.
Jump to section
Company mission
To provide neurodegenerative patients, starting with ALS and PD, access to the best care while fueling the advancement of personalized treatments.
Few candidates hear
back within 2 weeks
24% employee growth in 12 months
Our take
Synapticure is a Chicago-based tele-neurology company providing personalized care for patients and families affected by ALS (Amyotrophic Lateral Sclerosis), a progressive neurodegenerative disease that affects the nerve cells responsible for controlling voluntary muscles.
Through the company's tele-neurology platform, Synapticure's team of neurologists and healthcare professionals are able to remotely diagnose, monitor, and treat ALS patients, providing them with tailored healthcare plans and ongoing support. The company's approach aims to improve the quality of life for ALS patients and their families, by reducing the burden of in-person visits along with providing increased access to care.
With funding raised from several investment organizations, Synapticure is well-equipped to provide specialized care and support to ALS patients and their families, with the potential to make a significant impact on the management of ALS. Synapticure plans to utilize the capital it has gained to further scale its care platform to provide its services to people living with ALS across the United States.
Kirsty
Company Specialist at Welcome to the Jungle
Benefits
- 3 weeks of PTO
- Remote-first
- Fully insured medical, dental, vision and life insurance plans
- Matched 401k
Funding (2 rounds)
Nov 2024
$25m
SERIES A
Feb 2022
$6m
SEED
Total funding: $31m
This company has top investors
Leadership
Jason Langheier
(Co-Founder)CEO and founder of Foodsmart. Did neuroscience, genetics and bioinformatics research at Williams, Duke, Cambridge and NIH, and received his MD from Duke, and his MPH from Harvard.
Brian Wallach
(Co-Founder)Co-founder of I AM ALS. Previously served as an Assistant United States Attorney in the Northern District of Illinois and served as a Senior Vetting Counsel at the White House in the Obama Administration.
Sandra Abrevaya
(CEO & Co-Founder)Former founding CEO of Thrive Chicago. Previously served in senior roles for the City of Chicago, the U.S. House of Representatives, the U.S. Senate, the U.S. Department of Education and the White House.
Office
Articles
Jobs (3)
Data
Operations & Strategy
Finance, Legal & Compliance